Waiting
Login-Verarbeitung ...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / İnsan Hücre Lines Kemorezistans Yumurtalık Kanser …
JoVE Journal
Medicine

Ein Abonnement für JoVE ist erforderlich, um diesen Inhalt ansehen zu können. Melden Sie sich an oder starten Sie Ihre kostenlose Testversion.

JoVE Journal Medicine
İnsan Hücre Lines Kemorezistans Yumurtalık Kanser Kök Hücreleri Zenginleştirme
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Journal (Medicine)
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Journal (Medicine)
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
 
Click here for the English version

İnsan Hücre Lines Kemorezistans Yumurtalık Kanser Kök Hücreleri Zenginleştirme

Article DOI: 10.3791/51891-v • 11:50 min • September 10th, 2014
September 10th, 2014 •
1, 1, 1, 1
1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine

Kapitel

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Kanser kök hücreleri (rulmanları) nedeniyle kemoterapi direncinin tümör nüks sorumlu tutulmaktadır. Biz seçimi ve yumurtalık kanseri hücre hatları CSCS genişlemesi için bir protokol optimize ettik. Kemoterapötik Sisplatin ile hücrelerin tedavisi ve biz yapışmayan CSC kültürler için zenginleştirmek medyayı teşvik kök hücre kültürleme tarafından.

Tags

Tıp Sayı 91 kanser kök hücreler kök hücre belirleyicileri yumurtalık kanseri kemoterapi sisplatin kanser ilerlemesi
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter